By renewing the HTID® (HealthTech Innovation Days) an event dedicated to Biotech, Medtech and Digital Health companies on October 5 and 6 2020, France Biotech confirms its desire to promote access for all patients to cutting-edge HealthTech technologies.
In June 2019, the HTID® event brought together more than 500 innovation experts in the health and life sciences fields and promoted more than 900 fruitful meetings between the players present, startups and funds.
In October 2020, it is the interest of the patient who will be at the heart of France biotech's aspirations, proving that access to innovative care for all, depends on partnerships between actors in health and finance, in Europe and elsewhere.
Be part of the European investment hub supporting European HealthTech companies development. Accelerate innovation by setting a privilege place between C-level executives from the most European innovative companies in HealthTech, worldwide investors, pharmaceutical companies, KOLs, experts and institutional representatives.
France is home to the largest number of life sciences start-ups in Europe. This fast-moving industry is facing disruptive innovations, which generate myriad complex legal issues, and we are glad as an international law firm to work alongside France Biotech to support businesses in the sector.Managing partner of Dechert's Paris office
It was great to attend and support HTID’s first edition. As the only American pharma company partner, this event was the opportunity for us to formalize our desire to invest in innovation in France and increase our synergies with many start-ups. (...) France is definitely a center of excellence in e-health, artificial intelligence and big data but also in biotech start-ups. We hope to be there next year with possible new partners and wish to be even more involved in the French innovation ecosystem.Chairman of Amgen France
We are delighted to have participated to this 1st edition of the HTID. As a Belgian company, we can only applaud the support given by the French government to the European health ecosystem. In addition to bringing together the best companies in the sector and specialized investors, this event brings high visibility on a sector creating direct and indirect qualified jobs. Gathering all actors in this value chain can only be virtuous, allowing academic research to find an industrial outlet.CEO of Celyad
At least on-going Phase 1, financement available for Phase 2
CE or FDA filed (PMA, DeNovo, 510k, pre-subs) product
Innovative Med activities
Innovative services and functionalities under test by HealthTech partners
Services or functionalities in development with at least 1 fund raising
Want to work together?
Check out our partnership offers and join us on this must-attend HealthTech innovation event.
Become a part of the movement to foster stronger collaborations and partnerships within Europe to improve patient lives in the EU and beyond!